Our expertise
Our expertise
We unlock, activate and optimize value for pharma and biopharma at each pivotal moment.

Commercialization platform
We help you confidently navigate each pivotal moment across the lifecycle of your asset.

Therapeutic expertise
An unrivaled depth and diversity of expertise to support your healthcare innovation.

Sectors we serve
We’re trusted by the best in the industry to activate meaningful growth.
Business units

Overview
Discover a full-suite of connected capabilities that bring strategic expertise across every stage of your clinical development and commercialization journey.

Inizio Advisory
Leverage our connected Advisory expertise, technology platforms and data driven insights to help you make smart decisions.

Inizio Medical
Start creating compelling content and engage key communities with better scientific understanding across drug development and commercialization.

Inizio Evoke
Unlock the power of data and creativity with a global brand, experience, and communications platform, purpose-built to make health more human.

Inizio Engage
Uncover a mix of consultation, creation, and activation expertise for tailored solutions that inspire lasting change for patients, providers and payers.

Inizio Biotech
Discover best-in-class, highly personalized biotech solutions that guide, validate, and inspire the decisions that maximize your asset value at every opportunity.
Our capabilities
Connected capabilities
As a market-leading commercialization platform for pharma and biopharma, our connected expertise brings unparalleled breadth and depth of expertise and capabilities to even your most complex projects.
Our capabilities

Product launch
Our connected experts unlock, activate and optimize the value of your healthcare innovation at each pivotal moment of your product launch journey.

Data, tech & AI solutions
We continue to discover, build and share the most effective applications of human and artificial intelligence (AI) engagements through agile and responsible experimentation.

Omnichannel strategy
Maximizing the potential of every HCP and patient interaction with tailored omnichannel experiences.

Clinical development
Transforming scientific advancements into new standards of care.

Inizio Biotech
Maximize asset value at every opportunity.
About Inizio
Insights
View all insights
Unpacking our insights: What did we learn from Reuters USA 2024?

Discover the three key themes that our commercialization experts and thought leaders from across Inizio gathered at Reuters USA.
Read more

Insights from MAPS Americas 2024 in Puerto Rico

This article, delves into the key takeaways, exploring themes of collaboration, medical excellence, omnichannel strategy, patient centricity, and AI.
Read more

“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential

Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its...
Read more

2023 Mid-Year Update

The Directors of Inizio are pleased to present a mid-year update for 2023. Inizio is a product commercialization...
Read more

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance.

Learn how our client discovered a slowdown in the prescription of a key brand in a major market and needed to identify the impacted patient segments
Read more

Differentiating a product in a crowded market with best-in-class patient support

The challenge A top ten pharma company needed an innovative patient experience solution to help a new treatment for a...
Read more

Insights from MAPS Americas 2024 in Puerto Rico

This article, delves into the key takeaways, exploring themes of collaboration, medical excellence, omnichannel strategy, patient centricity, and AI.
Read more

ISMPP EU 2024 Report

Download Inizio Medical's ISMPP EU 2024 Report
Read more
Join Inizio

Contact

Sese Abhulimen

Managing Director, PROPENSITY4 - Inizio Engage

Sese is an experienced Commercial Analytics and Insight professional with cross industry expertise covering life sciences, financial services and retail apparel.

Starting as an analyst at Redcats USA, and later working as a Senior Statistician at IQVIA, his background in manipulating data led to his success in leading business insights teams while at AstraZeneca. In these roles and organizations, Sese successfully led several commercial insight processes and teams and implemented enterprise-wide commercial effectiveness innovation initiatives.

His expertise in narrowing in on data that builds powerful product and brand marketing programs, coupled with a passion for entrepreneurship drove him to create PROPENSITY4.